PortfoliosLab logoPortfoliosLab logo
EWTX vs. NVDA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EWTX vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edgewise Therapeutics Inc (EWTX) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EWTX achieves a 82.99% return, which is significantly higher than NVDA's 13.25% return.


EWTX

1D
-6.08%
1M
30.38%
6M
82.37%
YTD
82.99%
1Y
228.11%
3Y*
86.15%
5Y*
14.05%
10Y*

NVDA

1D
4.03%
1M
2.81%
6M
14.26%
YTD
13.25%
1Y
28.09%
3Y*
70.82%
5Y*
60.22%
10Y*
66.42%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EWTX vs. NVDA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
EWTX
Edgewise Therapeutics Inc
82.99%-7.06%144.06%22.37%-41.49%-43.41%
NVDA
NVIDIA Corporation
13.25%38.92%171.25%239.02%-50.26%134.75%

Correlation

The correlation between EWTX and NVDA is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Mar 26, 2021

0.20

Fundamentals

Market Cap

EWTX:

$4.89B

NVDA:

$5.11T

EPS

EWTX:

-$1.67

NVDA:

$6.53

PB Ratio

EWTX:

9.86

NVDA:

26.32

Total Revenue (TTM)

EWTX:

$0.00

NVDA:

$253.49B

Gross Profit (TTM)

EWTX:

$0.00

NVDA:

$187.95B

EBITDA (TTM)

EWTX:

-$188.16M

NVDA:

$192.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EWTX vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EWTX
EWTX Risk / Return Rank: 9797
Overall Rank
EWTX Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
EWTX Sortino Ratio Rank: 9696
Sortino Ratio Rank
EWTX Omega Ratio Rank: 9494
Omega Ratio Rank
EWTX Calmar Ratio Rank: 9999
Calmar Ratio Rank
EWTX Martin Ratio Rank: 9999
Martin Ratio Rank

NVDA
NVDA Risk / Return Rank: 6969
Overall Rank
NVDA Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
NVDA Sortino Ratio Rank: 6767
Sortino Ratio Rank
NVDA Omega Ratio Rank: 6464
Omega Ratio Rank
NVDA Calmar Ratio Rank: 7272
Calmar Ratio Rank
NVDA Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EWTX vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edgewise Therapeutics Inc (EWTX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EWTXNVDADifference
Sharpe ratioReturn per unit of total volatility

+2.24

Sortino ratioReturn per unit of downside risk

+2.44

Omega ratioGain probability vs. loss probability

1.45

1.16

+0.29

Calmar ratioReturn relative to maximum drawdown

11.69

1.43

+10.26

Martin ratioReturn relative to average drawdown

31.03

3.09

+27.93

EWTX vs. NVDA - Sharpe Ratio Comparison

The current EWTX Sharpe Ratio is 3.05, which is higher than the NVDA Sharpe Ratio of 0.81. The chart below compares the historical Sharpe Ratios of EWTX and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EWTX vs. NVDA - Drawdown Comparison

The maximum EWTX drawdown since its inception was -84.69%, smaller than the maximum NVDA drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for EWTX and NVDA.


Loading charts...

Drawdown Indicators


EWTXNVDADifference

Max Drawdown

Largest peak-to-trough decline

-84.69%

-89.72%

+5.03%

Max Drawdown (1Y)

Largest decline over 1 year

-19.59%

-20.21%

+0.62%

Max Drawdown (3Y)

Largest decline over 3 years

-68.81%

-36.88%

-31.93%

Max Drawdown (5Y)

Largest decline over 5 years

-75.41%

-66.34%

-9.07%

Max Drawdown (10Y)

Largest decline over 10 years

-66.34%

Current Drawdown

Current decline from peak

-6.08%

-10.41%

+4.33%

Average Drawdown

Average peak-to-trough decline

-52.82%

-36.12%

-16.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.36%

9.32%

-1.96%

Volatility

EWTX vs. NVDA - Volatility Comparison

Edgewise Therapeutics Inc (EWTX) has a higher volatility of 18.76% compared to NVIDIA Corporation (NVDA) at 10.90%. This indicates that EWTX's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EWTXNVDADifference

Volatility (1M)

Calculated over the trailing 1-month period

18.76%

10.90%

+7.86%

Volatility (6M)

Calculated over the trailing 6-month period

43.95%

27.21%

+16.74%

Volatility (1Y)

Calculated over the trailing 1-year period

75.13%

35.49%

+39.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.67%

51.83%

+29.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.06%

49.87%

+31.19%

Dividends

EWTX vs. NVDA - Dividend Comparison

EWTX has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.13%.


PositionTTM20252024202320222021202020192018201720162015
EWTX
Edgewise Therapeutics Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.13%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%

Financials

EWTX vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Edgewise Therapeutics Inc and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April0
81.62B
(EWTX) Total Revenue
(NVDA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


EWTX and NVDA have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EWTX has higher volatility (18.76%) compared to NVDA (10.90%). In terms of maximum drawdown, EWTX dropped -84.69% vs NVDA's -89.72%.

EWTX currently has the higher Sharpe Ratio (3.05 vs 0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EWTX and NVDA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer